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Preliminary and Short Report
GRISEOFULVIN POTENTIATION OF COLCHICINE TOXICITY*
WILLIAM L. EPSTEIN, M.D. AND MELFORD A. LARSON, B.S.
The mechanism of action of griseofulvin, a new
oral antifungal agent, is unknown. Paget and
Walpole (1) found that very large doses caused
mitotic arrest at metaphase similar to that in-
duced by colchicine. McNall (2) observed reversal
of griseofulvin fungistasis by purines and related
compounds. He suggested that griseofulvin acts
by direct interference with the synthesis of nucleic
acid. Coichicine likewise affects nucleic acid me-
tabolism by inhibiting nuclease and nucleotidase
(3, 4). On the basis of these similarities griseo-
fulvin is receiving clinical trials in the treatment
of gout (5). The present study deals with
the effects of combined administration to mice of
griseofulvin and colchicine.
MATERIALS AND METHODS
Swiss albino mice weighing 18 to 30 grams were
divided into groups of 10 each and housed in
separate pens. They were fed standard mouse
pellets and given water ad 115. Colehicine in amber
bottles, 0.5 mg/ml in salinet, was kept in the re-
frigerator and diluted before use. Griseofulvint,
supersaturated at 50 mg/ml in olive oil, was made
up fresh before each experiment. All injections
were given intraperitoneally in separate single
doses.
The incidence of mortality was determined first
for each compound alone. After injection the
animals were observed daily for 2 weeks and peri-
odically thereafter for 2 months. In the second
experiment a non-lethal dose of griseofulviu was
administered at the same time as increasing doses
of colchicine. In the third series a non-lethal dose
of colchicine was given simultaneously with
graded aliquots of griseofulvin. Suitable controls
were used throughout.
RESULTS
The incidence of mortality for each compound
alone is recorded in Figure 1. Obviously colchicine
is very toxic; griseofulvin, nearly nontoxic. Al-
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t Colchicine—Lilly Ampoules 656
Griseofulvin—in dry, sterlle powder, supplied
by Dr. Clarence Denton, McNeil Laboratories,
Inc., Philadelphia.
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most all deaths occurred within 7 days; very few
animals died after that. There was no tendency
for late mortality. It should be noted that the in-
cidence of mortality from griseofulvin in olive oil
is considerablylower than that reported by Sharpe
and Tomich (6). They used griseofulvin in aqueous
suspension. It seems that an olive oil vehicle per-
mits slower release of griseofulvin. Autopsies 2
weeks after injection of griseofulvin in olive oil
revealed significant amounts of the drug still in
the peritoneal cavity. Similarly, injections of
griseofulvin in oil produce more sustained skin
levels than do injections of aqueous suspensions
(7).
After simultaneous administration of griseo-
fulvin and colchicine, a marked increase in the in-
cidence of mortality was observed (Fig. 2). The
response followed a dosage-response distribution;
colchicine, in 1 mg/kg amounts normally non-
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lethal, caused 20 per cent mortality when given
with 1 Gm/kg of griseofulvin and 90 per cent mor-
tality when given with 2 Gm/kg of griseofulvin. At
lower doses of colchicine, 0.5 mg/kg, even 4 Gm/kg
of griseofulvin produced no deaths. Apparently
griseofulvin potentiation does not occur below a
threshold amount of coichicine.
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These data are incomplete and do not allow a
complete probit analysis of synergism of drug ac-
tion. Nevertheless, these findings strongly suggest
that moderately large doses of griseofulvin en-
hance the acute toxic effects of colchicine. Even a
normally non-lethal amount of colchicine, 1
mg/kg, causes death when injected with griseo-
fulvin. We have no idea how this potentiation
comes about. Respiratory arrest is usually stated
as the cause of colchicine death (8). Conceivably
a combined direct or indirect effect on nncleic
acid metabolism could result in a generalized
failure of DNA synthesis and rapid demise. Many
other possibilities exist and more data is required
to develop a reasonable theory.
A practical point emerges. Combined therapy of
gout with griseofulvin and colchicine should be
undertaken with caution until more is known
about their combined toxicity in man. In the same
light it will be important to learn how griseofulvin
influences the antimitotic effects of x-ray and
radiomimetic drugs.
sUMMARY
Griseofulvin administered intraperitoneally in
non-lethal doses to mice receiving small doses of
colchicine (1 to 2 mg/kg) produced a marked in-
crease in mortality. This finding may bear on the
mechanism of action of these drugs. Combined
therapy with colchicine and griseofulvin in man
should be pursued cautiously until the extent of
potentiation of untoward symptoms is deter-
mined.
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